UPPER RESPIRATORY DISEASE
Clinical trials for UPPER RESPIRATORY DISEASE explained in plain language.
Never miss a new study
Get alerted when new UPPER RESPIRATORY DISEASE trials appear
Sign up with your email to follow new studies for UPPER RESPIRATORY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug fights common cold to protect vulnerable lungs
Disease control CompletedThis study tested an experimental drug called vapendavir to see if it could reduce serious lung symptoms in people with COPD after they caught a common cold virus. Researchers gave the drug or a placebo to 52 adults with moderate COPD who were then exposed to the virus. The main …
Matched conditions: UPPER RESPIRATORY DISEASE
Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Head-to-Head vaccine showdown: which COVID booster works better?
Prevention CompletedThis study aimed to find out which of two updated COVID-19 booster vaccines—Novavax or Pfizer's mRNA vaccine—better protects adults from getting sick with COVID-19. It also compared protection in people who got a booster to those who did not. Over 1,100 adults in Utah participate…
Matched conditions: UPPER RESPIRATORY DISEASE
Phase: PHASE4 • Sponsor: Sarang K. Yoon, DO, MOH • Aim: Prevention
Last updated Mar 30, 2026 14:29 UTC